Ask VialBase
other

Svetinorm

Also known as: Svetinorm liver bioregulator, Liver Cytomax, Hepatic peptide bioregulator
Anecdotal evidence FDA: not-FDA-approved WADA: Not listed

Svetinorm is a liver "Cytomax" — a natural polypeptide complex purified from the liver tissue of young animals, in the Khavinson bioregulator family. It is marketed as a hepatoprotective bioregulator for liver-cell regeneration and used in Russian clinical practice for fatty liver, alcohol/toxin damage, and hepatitis recovery. Unlike the better-studied synthetic peptides, no Svetinorm-specific study is indexed in PubMed — its proposed mechanism is inferred from named research on the liver organ-extract class and the broader Khavinson short-peptide literature. It is the natural organ-extract counterpart to the synthetic liver Cytogen Livagen. It is not FDA-approved. For educational purposes only. Not

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight Not defined — natural polypeptide complex (Cytomax), not a single molecule
Half-life ~minutes estimated;
CAS number —
Route Subcutaneous · Oral subcutaneous preferred
02

Mechanism

Liver "Cytomax" — a natural polypeptide complex purified from the liver tissue of young animals, in the Khavinson bioregulator family. Unlike the synthetic liver Cytogen Livagen (a defined tetrapeptide), Svetinorm is a tissue-derived mixture of peptides with no single defined sequence. Like the rest of the family it is proposed to act through tissue-specific bioregulation — reintroducing the regulatory peptide signals of a young liver to normalize gene expression in aged or damaged hepatic tissue. Note: there is no Svetinorm-specific peer-reviewed study indexed in PubMed; the mechanism is inferred from named research on the liver-peptide-complex class (organ-extract "cytomedins" such as hepalin) and the broader Khavinson short-peptide literature.

03

Dosing

DOSE RANGE 10–20 mg per cycle
FREQUENCY 1×/day
CYCLE LENGTH 10–20 days, repeated up to 4×/year

Traditional Khavinson-style pulsed cycles from practitioner/vendor protocols. No controlled dosing study exists for Svetinorm specifically. Vendor material describes oral and SubQ routes, though classic Cytomaxes are injection-first in Russian clinical practice; no bioavailability data is published.

04

Stacking & interactions

Same-organ liver pairing — natural liver Cytomax (Svetinorm) + synthetic liver Cytogen (KEDA tetrapeptide)

Comprehensive gut–liver healing

Longevity protocol — hepatic + pineal/telomere axes

Organ-detox / tissue-repair stacks

05

Sourcing

Stocks this compound Third-party tested Public COAs Positive rep

Save 15% with code VIALBASE at checkout

VialBase may earn a commission on purchases through partner links — never at additional cost to you. Full disclosure.

What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE
  • CMP
  • CBC
  • Liver Panel (ALT, AST, GGT, bilirubin, albumin)
DURING CYCLE
  • Liver Panel
POST-CYCLE
  • CMP
  • Liver Panel
Safety & Regulatory Status
FDA STATUS not-FDA-approved
WADA STATUS Not listed

Regulatory status for Svetinorm may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.

Frequently Asked Questions

What is Svetinorm?
Svetinorm is a liver "Cytomax" — a natural polypeptide complex extracted from the liver tissue of young animals, in the Khavinson bioregulator family. It is marketed as a hepatoprotective bioregulator for liver-cell regeneration and is used in Russian clinical practice for fatty liver, alcohol/toxin damage, and hepatitis recovery. It is the natural organ-extract counterpart to the synthetic liver Cytogen Livagen.
Is there real research on Svetinorm?
This is the honest part: there is no Svetinorm-specific study indexed in PubMed — no clinical trial and no named in vitro paper. Its composition is documented only in vendor material. What exists is named Russian preclinical evidence for the liver organ-extract class: liver "cytomedins" (hepalin) stimulating hepatic tissue growth in organotypic culture (PMID: 11213728; PMID: 12096446), and a polypeptide liver complex showing hepatoprotective effects in liver-fibrosis and hepatitis models (PMID: 32362099). Svetinorm's specific claims are extrapolated from that body of work — treat them as plausible-but-unproven for this exact product.
How does Svetinorm differ from Livagen?
They target the same organ but differ in origin. Svetinorm is a Cytomax — a natural multi-peptide liver extract with no single defined sequence. Livagen is a Cytogen — a single synthetic tetrapeptide, Lys-Glu-Asp-Ala (KEDA). Livagen has a reported human chromatin-activation mechanism (sibling evidence, not cited here); Svetinorm has no compound-specific study of its own. The tradition is to pair the two as same-organ siblings.
How is Svetinorm dosed?
Practitioner and vendor protocols use short pulsed courses of about 10–20 mg per cycle for 10–20 days, repeated up to four times a year, by subcutaneous injection or orally. These are traditional Khavinson-style regimens, not trial-validated doses, and no standardized per-lot reconstitution protocol is published for this complex.
Is Svetinorm FDA-approved or safe for the liver?
No. Svetinorm is not FDA-approved and is sold only as a research chemical. It is used within Russian hepatology/bioregulatory practice and is generally reported as well tolerated, but controlled human safety and efficacy data do not exist. Anyone with liver disease should be managed by a physician rather than relying on an unproven peptide.